tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 1 analysts with an average price target of $19.01. This is a potential upside of $14.66 (337.01%) from yesterday's end of day stock price of $4.35.
I-Mab's activity chart (see below) currently has 15 price targets and 23 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 124.6 days.
Highest price target for IMAB is $1, Lowest price target is $1.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 03-Apr-2025. First documented stock forecast 10-Feb-2020.
Currently out of the existing stock ratings of IMAB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6 months 3 days ago
(03-Apr-2025)
1/2 (50%)
$23.19 (32.29%)
85
Buy
$5
$0.65 (14.94%)
$16
1 years 7 months 25 days ago
(11-Feb-2024)
2/2 (100%)
$3.2 (177.78%)
314
Buy
$8
$3.65 (83.91%)
1 years 7 months 29 days ago
(07-Feb-2024)
0/2 (0%)
$6.21 (346.93%)
Buy
$35
2 years 6 months 3 days ago
(03-Apr-2023)
1/4 (25%)
$26.73 (323.22%)
91
Buy
$90
$85.65 (1968.97%)
$76
4 years 3 months 28 days ago
(08-Jun-2021)
3/4 (75%)
$13.97 (18.37%)
133
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
